Rhett Shirley is an Infectious Disease physician affiliated with Prisma Health. OpenAlex indexes 11 publications with 348 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
890 W Faris Rd
Suite 520
Greenville, SC 296054253
Telephone
864-455-9033Provider last certified this registry record 18 Feb 2025.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20247 payments
- Merck Sharp & Dohme LLCProgram year20245 payments
- ABBVIE INC.Program year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Short-acting sulfonamides19.4%Sulfamethoxazole-Trimethoprim100%Part D≥11 patientsFirst-generation cephalosporins18%Cefadroxil100%Part D≥11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 906. Impact of Accelerate Rapid Diagnostic Technology on Time to Optimal Antimicrobial Therapy in Gram Negative Bloodstream Infection
Open Forum Infectious Diseases
2022 - Association between Vancomycin-Resistant Enterococci Bacteremia and Ceftriaxone Usage
Infection Control and Hospital Epidemiology
2012
Similar KOLs
Other experts from the same institution or the same specialty.
Gopi Dandamudi, MD
Prisma Health
Ezequiel Gleichgerrcht, MD, PhD
Prisma Health
Anthony Gregg, MD
Prisma Health
Fredy Revilla, MD
Prisma Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”